Nasopharyngeal bacterial burden and antibiotics: Influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis

Journal of Infection

Volumn 71, Issue 4, 2015, Pages 458-469

  Suárez Arrabal, M Carmen ^a,d   Mella, Cesar ^a,b,e   Lopez, Santiago M ^a   Brown, Nicole V ^c   Hall, Mark W ^b   Hammond, Sue ^b   Shiels, William ^b   Groner, Judith ^b   Marcon, Mario ^b   Ramilo, Octavio ^a,b   Mejias, Asuncion ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotics; Bronchiolitis; Disease severity; Gram negative bacteria; Nasopharyngeal bacterial colonization; RSV

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; INTERLEUKIN 18; INTERLEUKIN 6; MACROLIDE; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CYTOKINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BETA HEMOLYTIC STREPTOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFECTION RISK; INFLAMMATORY CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; NASOPHARYNX; NEUTROPHIL COUNT; NOSE SMEAR; OBSERVATIONAL STUDY; OXYGEN THERAPY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; VIRAL BRONCHIOLITIS; BACTERIAL LOAD; BLOOD; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STREPTOCOCCUS; VIROLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BIOMARKERS; BRONCHIOLITIS, VIRAL; CYTOKINES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMANS; INFANT; MALE; MORAXELLA (BRANHAMELLA) CATARRHALIS; NASOPHARYNX; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84941647372     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.06.010     Document Type: Article

References (49)

1. Shay D.K., Holman R.C., Newman R.D., Liu L.L., Stout J.W., Anderson L.J. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999, 282:1440-1446.
2. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
3. Groothuis J.R., Hoopes J.M., Jessie V.G. Prevention of serious respiratory syncytial virus-related illness. I: disease pathogenesis and early attempts at prevention. Adv Ther 2011, 28:91-109.
4. Langley G.F., Anderson L.J. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011, 30:510-517.
5. Kristensen K., Hjuler T., Ravn H., Simoes E.A., Stensballe L.G. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012, 54:810-817.
6. Bloemers B.L., van Furth A.M., Weijerman M.E., Gemke R.J., Broers C.J., van den Ende K., et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis-a prospective birth-cohort study. Pediatrics 2007, 120:e1076-81.
7. Garcia C.G., Bhore R., Soriano-Fallas A., Trost M., Chason R., Ramilo O., et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010, 126:e1453-60.
8. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009, 360:588-598.
9. Mella C., Suarez-Arrabal M.C., Lopez S., Stephens J., Fernandez S., Hall M.W., et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2013, 207:564-573.
10. Pettigrew M.M., Gent J.F., Revai K., Patel J.A., Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis 2008, 14:1584-1591.
11. Murphy T.F., Bakaletz L.O., Smeesters P.R. Microbial interactions in the respiratory tract. Pediatr Infect Dis J 2009, 28:S121-S126.
12. Xu Q., Almudervar A., Casey J.R., Pichichero M.E. Nasopharyngeal bacterial interactions in children. Emerg Infect Dis 2012, 18:1738-1745.
13. Hament J.M., Aerts P.C., Fleer A., Van Dijk H., Harmsen T., Kimpen J.L., et al. Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus. Pediatr Res 2004, 55:972-978.
14. McGillivary G., Mason K.M., Jurcisek J.A., Peeples M.E., Bakaletz L.O. Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cell Microbiol 2009, 11:1399-1408.
15. Ampofo K., Bender J., Sheng X., Korgenski K., Daly J., Pavia A.T., et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008, 122:229-237.
16. Weinberger D.M., Givon-Lavi N., Shemer-Avni Y., Bar-Ziv J., Alonso W.J., Greenberg D., et al. Influence of pneumococcal vaccines and syncytial virus on alveolar pneumonia, Israel. Emerg Infect Dis 2013, 19:1084-1091.
17. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10:811-813.
18. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Edwards K.K., et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005, 118:285-291.
19. Techasaensiri B., Techasaensiri C., Mejias A., McCracken G.H., Ramilo O. Viral coinfections in children with invasive pneumococcal disease. Pediatr Infect Dis J 2010, 29:519-523.
20. Weinberger D.M., Klugman K.P., Steiner C.A., Simonsen L., Viboud C. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. PLoS Med 2015, 12:e1001776.
21. Esposito S., Zampiero A., Terranova L., Ierardi V., Ascolese B., Daleno C., et al. Pneumococcal bacterial load colonization as a marker of mixed infection in children with alveolar community-acquired pneumonia and respiratory syncytial virus or rhinovirus infection. Pediatr Infect Dis J 2013, 32:1199-1204.
22. Yu D., Wei L., Zhengxiu L., Jian L., Lijia W., Wei L., et al. Impact of bacterial colonization on the severity, and accompanying airway inflammation, of virus-induced wheezing in children. Clin Microbiol Infect 2010, 16:1399-1404.
23. Jartti T., Kuneinen S., Lehtinen P., Peltola V., Vuorinen T., Leinonen M., et al. Nasopharyngeal bacterial colonization during the first wheezing episode is associated with longer duration of hospitalization and higher risk of relapse in young children. Eur J Clin Microbiol Infect Dis 2011, 30:233-241.
24. Ralston S.L., Lieberthal A.S., Meissner H.C., Alverson B.K., Baley J.E., Gadomski A.M., et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014, 134:e1474-502.
25. Gualdi L., Mertz S., Gomez A.M., Ramilo O., Wittke A., Mejias A. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Antiviral Res 2013, 99:188-195.
26. Garcia C., Soriano-Fallas A., Lozano J., Leos N., Gomez A.M., Ramilo O., et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 2012, 31:86-89.
27. Mejias A., Dimo B., Suarez N.M., Garcia C., Suarez-Arrabal M.C., Jartti T., et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med 2013, 10:e1001549.
28. Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18:115-122.
29. Gill M.A., Palucka A.K., Barton T., Ghaffar F., Jafri H., Banchereau J., et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis 2005, 191:1105-1115.
30. Malley R., DeVincenzo J., Ramilo O., Dennehy P.H., Meissner H.C., Gruber W.C., et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998, 178:1555-1561.
31. Gill M.A., Long K., Kwon T., Muniz L., Mejias A., Connolly J., et al. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis 2008, 198:1667-1676.
32. Forbes B.A., Sahm D.F., Weissfeld A.S., Bailey W.R. Bailey & Scott's diagnostic microbiology 2007, Elsevier Mosby, St. Louis, MO. 12th ed.
33. Hall M.W., Gavrilin M.A., Knatz N.L., Duncan M.D., Fernandez S.A., Wewers M.D. Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr Res 2007, 62:597-603.
34. Avadhanula V., Wang Y., Portner A., Adderson E. Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein. J Med Microbiol 2007, 56:1133-1137.
35. Stark J.M., Stark M.A., Colasurdo G.N., LeVine A.M. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Virol 2006, 78:829-838.
36. Jordan-Villegas A., Chang M., Khohar S., Gomez A.M., McCracken G.H., Mejias A., et al. Respiratory syncytial virus (RSV) infection predisposes mice to severe pneumococcal disease and bacteremia 2010, Infectious Diseases Society of America 48th Annual Meeting.
37. Smith C.M., Sandrini S., Datta S., Freestone P., Shafeeq S., Radhakrishnan P., et al. Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med 2014, 190:196-207.
38. Purcell K., Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J 2004, 23:267-269.
39. Levine D.A., Platt S.L., Dayan P.S., Macias C.G., Zorc J.J., Krief W., et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004, 113:1728-1734.
40. Andrade M.A., Hoberman A., Glustein J., Paradise J.L., Wald E.R. Acute otitis media in children with bronchiolitis. Pediatrics 1998, 101:617-619.
41. Gomaa M.A., Galal O., Mahmoud M.S. Risk of acute otitis media in relation to acute bronchiolitis in children. Int J Pediatr Otorhinolaryngol 2012, 76:49-51.
42. Florin T.A., Byczkowski T., Ruddy R.M., Zorc J.J., Test M., Shah S.S. Variation in the management of infants hospitalized for bronchiolitis persists after the 2006 American Academy of Pediatrics bronchiolitis guidelines. J Pediatr 2014, 165:786-792 e1.
43. Johnson L.W., Robles J., Hudgins A., Osburn S., Martin D., Thompson A. Management of bronchiolitis in the emergency department: impact of evidence-based guidelines?. Pediatrics 2013, 131(Suppl. 1):S103-S109.
44. Akenroye A.T., Baskin M.N., Samnaliev M., Stack A.M. Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics 2014, 133:e227-34.
45. Parikh K., Hall M., Teach S.J. Bronchiolitis management before and after the AAP guidelines. Pediatrics 2014, 133:e1-7.
46. Hishiki H., Ishiwada N., Fukasawa C., Abe K., Hoshino T., Aizawa J., et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother 2011, 17:87-90.
47. Vu H.T., Yoshida L.M., Suzuki M., Nguyen H.A., Nguyen C.D., Nguyen A.T., et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011, 30:11-18.
48. DeVincenzo J.P., El Saleeby C.M., Bush A.J. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005, 191:1861-1868.
49. Bamberger E., Srugo I., Abu Raya B., Segal E., Chaim B., Kassis I., et al. What is the clinical relevance of respiratory syncytial virus bronchiolitis?: findings from a multi-center, prospective study. Eur J Clin Microbiol Infect Dis: Official Publ Eur Soc Clin Microbiol 2012, 31:3323-3330.